AI

It seems we can’t find what you’re looking for. Perhaps searching can help.

Lilly has announced a tie-up with the WHO Foundation to financially support the aims of the WHO’s global dementia action plan.

October 14, 2025

Lilly tight-lipped over WHO Foundation dementia deal

US drugmaker Lilly has refused to disclose the amount it is giving as part of a dementia deal with the WHO Foundation. The company announced…

The Global Dengue Observatory provides an estimate of the current global dengue situation. Image courtesy of Global Dengue Observatory

March 9, 2026

Real-time data on global dengue outbreaks

Wider use of existing brain health treatments could add $6.2 trillion to global economic output every year from 2050.

November 5, 2025

Davos brain health plan hopes to unlock Africa funds

Strong performance in its long-acting HIV preventable has helped GlaxoSmithKline to raise its profit forecasts

October 31, 2025

GSK’s Q3 results buoyed by long-acting HIV jab

South Africa's Minister of Health Aaron Motsoaledi said the country plans to make Gilead’s twice-yearly HIV preventative lenacapavir into a 'public good'

October 27, 2025

South Africa to make Gilead’s lenacapavir a ‘public good’

At the Seventh Replenishment summit in 2022, the US committed $6 billion, out of a record $15 billion raised.

October 22, 2025

Viiv/GSK pledge $8 mln ahead of Global Fund summit

GSK and HIV specialist ViiV Healthcare have pledged $8 million to the Global Fund, representing the biggest commitment to date from a private sector company…

October 27, 2025

South Africa to make Gilead’s lenacapavir a ‘public good’

October 14, 2025

Lilly tight-lipped over WHO Foundation dementia deal

Two private equity firms bidding for Bavarian Nordic have increased their offer for the Danish maker of vaccines for mpox, cholera and chikungunya.

October 15, 2025

Suitors up price for Bavarian Nordic

The US has so far funded a third of the cost of fighting mpox.

March 19, 2025

AI

Popular Articles

Lilly tight-lipped over WHO Foundation dementia deal

Real-time data on global dengue outbreaks

Davos brain health plan hopes to unlock Africa funds

GSK’s Q3 results buoyed by long-acting HIV jab

South Africa to make Gilead’s lenacapavir a ‘public good’

Random Articles

Viiv/GSK pledge $8 mln ahead of Global Fund summit

South Africa to make Gilead’s lenacapavir a ‘public good’

Lilly tight-lipped over WHO Foundation dementia deal

Suitors up price for Bavarian Nordic

US aid suspension threatens mpox fight

Receive our weekly briefing on AI in global health

From our team of writers around the world